Literature DB >> 15972217

The activation of memory CD4(+) T cells and CD8(+) T cells in patients with multiple sclerosis.

Yoshinobu Okuda1, Misa Okuda, Brian R Apatoff, David N Posnett.   

Abstract

To reevaluate whether an association exists between the clinical course of multiple sclerosis (MS) and the activation of memory T cells, we investigated the phenotype of T cells in peripheral blood and cerebrospinal fluid (CSF) of patients with MS using five-color flow cytometry. A cross-sectional study with 39 relapsing-remitting MS patients demonstrated that the percentage of CD25(+)CD45RO(+)CD4(+)CD3(+) cells was significantly increased in peripheral blood as well as in CSF of active MS patients compared with inactive MS patients. A longitudinal study with 11 relapsing-remitting MS patients also showed a higher percentage of CD25(+)CD45RO(+)CD4(+)CD3(+) cells in peripheral blood at the phase of exacerbation than during remission. On the other hand, regardless of the disease activity, the percentage of CD25(+)CD45RO(+)CD8(+)CD3(+) cells in peripheral blood was significantly higher in patients with MS than in healthy control subjects. A lower percentage of CD25(+)CD45RO(+)CD8(+)CD3(+) cells in CSF was observed in active MS patients compared with inactive MS patients. These results suggest that the activation of memory CD4(+) T cells is associated with the exacerbation of MS and activation of memory CD8(+) T cells reflects systemic immunological dysregulation in MS patients. Transient as well as continuous activation of T cells by recall antigens may be involved in the disease course of MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972217     DOI: 10.1016/j.jns.2005.02.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.

Authors:  Lindsay M Webb; Stephanie A Amici; Kyle A Jablonski; Himanshu Savardekar; Amanda R Panfil; Linsen Li; Wei Zhou; Kevin Peine; Vrajesh Karkhanis; Eric M Bachelder; Kristy M Ainslie; Patrick L Green; Chenglong Li; Robert A Baiocchi; Mireia Guerau-de-Arellano
Journal:  J Immunol       Date:  2017-01-13       Impact factor: 5.422

2.  Dimethyl fumarate may still have a role in progressive multiple sclerosis.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  Ther Adv Neurol Disord       Date:  2016-04-06       Impact factor: 6.570

3.  Expression of CCR7 and CD45RA in CD4+ and CD8+ subsets in cerebrospinal fluid of 134 patients with inflammatory and non-inflammatory neurological diseases.

Authors:  Katherine M Mullen; Anne R Gocke; Rameeza Allie; Achilles Ntranos; Inna V Grishkan; Carlos Pardo; Peter A Calabresi
Journal:  J Neuroimmunol       Date:  2012-05-24       Impact factor: 3.478

4.  Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.

Authors:  Marina Zafranskaya; Patrick Oschmann; Rosel Engel; Andreas Weishaupt; Johannes M van Noort; Hassan Jomaa; Matthias Eberl
Journal:  Immunology       Date:  2006-12-18       Impact factor: 7.397

5.  Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects.

Authors:  Emily L Ho; Rollie Ronquillo; Hermann Altmeppen; Serena S Spudich; Richard W Price; Elizabeth Sinclair
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

Review 6.  Multiple Sclerosis and Obesity: Possible Roles of Adipokines.

Authors:  José de Jesús Guerrero-García; Lucrecia Carrera-Quintanar; Rocío Ivette López-Roa; Ana Laura Márquez-Aguirre; Argelia Esperanza Rojas-Mayorquín; Daniel Ortuño-Sahagún
Journal:  Mediators Inflamm       Date:  2016-09-18       Impact factor: 4.711

7.  In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.

Authors:  Sreeja Varghese; Michelle Cotter; Franciane Chevot; Claire Fergus; Colm Cunningham; Kingston H Mills; Stephen J Connon; John M Southern; Vincent P Kelly
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

8.  NF-κB/mTOR/MYC Axis Drives PRMT5 Protein Induction After T Cell Activation via Transcriptional and Non-transcriptional Mechanisms.

Authors:  Lindsay M Webb; Janiret Narvaez Miranda; Stephanie A Amici; Shouvonik Sengupta; Gregory Nagy; Mireia Guerau-de-Arellano
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

9.  Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.

Authors:  Ewa Kozela; Ana Juknat; Fuying Gao; Nathali Kaushansky; Giovanni Coppola; Zvi Vogel
Journal:  J Neuroinflammation       Date:  2016-06-03       Impact factor: 8.322

10.  Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration.

Authors:  Claudia La Rocca; Fortunata Carbone; Veronica De Rosa; Alessandra Colamatteo; Mario Galgani; Francesco Perna; Roberta Lanzillo; Vincenzo Brescia Morra; Giuseppe Orefice; Ilaria Cerillo; Ciro Florio; Giorgia Teresa Maniscalco; Marco Salvetti; Diego Centonze; Antonio Uccelli; Salvatore Longobardi; Andrea Visconti; Giuseppe Matarese
Journal:  Metabolism       Date:  2017-09-08       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.